DORIC NIMROD ORD PRF SHS NPV


Updates from The Motley Fool

Latest updates on Doric Nimrod Air One Ltd from Fool.com.  The Fool has written over 100 articles on Doric Nimrod Air One Ltd.
The March Mayhem Effect

You've heard of the "January Effect," in which investors sell stocks in December for tax reasons,...

2 Suitors Are Better Than 1

Marriage proposals aside -- and some might argue even in those cases -- it's almost always better...

Will It Ever End?

Surprise, surprise. Genentech 's ( NYSE: DNA     ) Special Committee of its Board of Directors...

Buyout or Sellout?

From tiny acquisitions to massive conglomerate combinations, Wall Street's urge to merge remains ...

3 Stocks That Missed the Mark

These three companies just didn't live up to Mr. Market's expectations last week. Sometimes an ea...

Sealed Lips Don't Sink Ships

Yesterday ended the annual January ritual of thousands of health care investors descending upon S...

Genentech Exhales

Genentech 's ( NYSE: DNA     ) investors got to breathe a sigh of relief yesterday. The comp...

Today's 5-Star Movers

As fundamentals-focused long-term investors, Fools never base an investment decision on the daily...

Genentech Asks Roche to Pay Up

In one of the more friendly spurnings of a buyout offer in recent months, Genentech ( NYSE: DN...

Buyout or Sellout?

From tiny acquisitions to massive conglomerate combinations, Wall Street's urge to merge remains ...

Monday's Biggest Stock Stars

Hey there, Fools. I've summoned our Motley Fool CAPS community once again to highlight Monday's...

Today's 5-Star Movers

As fundamentals-focused long-term investors, Fools never base an investment decision on the daily...

3 Stocks Hitting High Notes

Stocks hitting fresh highs can either signal that a stock is on its way to greatness or that i...

The Fool's Look Ahead

Monday Biotech bellwether Genentech ( NYSE: DNA     ) kicks off the new trading week with the...

A Tale of 2 DNA Drugs

While Genentech 's ( NYSE: DNA     ) lead drug, Avastin, has produced a string of successes th...

Not a Bad Quarter for Genentech

What do you call it when a biopharma giant musters double-digit percentage sales growth on two of...

A New Upgrade for Genentech

Every day, the sun rises on Wall Street and a plethora of professional analysts wake to issue new...

Genentech Takes Center Stage

Were you one of those Genentech ( NYSE: DNA     ) investors who didn't follow the 216-slide p...



Stock Performance

View Interactive DNA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Doric Nimrod Air One Ltd.
Current Price: $115.00
Prev Close: $114.00
Open: $114.00
Bid: $0.00
Ask: $0.00
Day's Range: $115.00 - $115.00
52wk Range: $107.00 - $117.00
Volume: 5,000
Avg Vol 15,335
Market Cap: $5B
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Doric Nimrod Air One Ltd.
CAPS Rating 0 out of 5
 
0 Outperform
0 Underperform
CAPS All Stars
 
0 Outperform
0 Underperform

How do you think Doric Nimrod Air One Ltd will perform against the market?



You pick for Doric Nimrod Air One Ltd is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Doric Nimrod Air One Ltd.

DORIC NIMROD ORD PRF SHS NPV

  • Exchange: LSE